Business
Tenet Healthcare operates acute-care hospitals and related healthcare services and owns a majority interest in USPI, its ambulatory surgery platform.
TENET HEALTHCARE CORP: Revenue grew 3.1% to $21.31B from $20.675B. Net income declined 41.8% to $2.367B from $4.064B. Free cash flow grew 126.7% to $2.53B from $1.116B. Operating margin contracted 1235 bps to 16.46%. TENET HEALTHCARE CORP's annual comparison also shows stock compensation grew faster than revenue; capital spending grew faster than revenue.
The read at a glance✓ Audited against SEC data
- Growth — Revenue grew 3.1%OK
- Profitability — Net income declined 41.8% to $2.367B from $4.064BWatch
- Cash flow — Free cash flow grew 126.7% to $2.53B from $1.116BOK
- Margins — Operating margin contracted 1235 bps to 16.46%Watch
- Accounting — No overriding statistical warningNote
- Insiders — 0 purchases and 16 salesWatch
Where the revenue comes from
Fiscal 2025, as TENET HEALTHCARE CORP reports it. History and quarterly detail are in the app.
- Hospital Operations$16.1B
- Ambulatory Care$5.2B
Leadership changes
From TENET HEALTHCARE CORP's own filings, the day they're filed.
- Paola Arbour · Chief Information Officer · departureeff. 2026-12-31
- J. Michael Grooms · Principal Accounting Officer · appointmenteff. 2026-04-06
- R. Scott Ramsey · departureeff. 2026-03-31
Latest filings
- 10-Q · Quarterly report2026-07-29
- 8-K · Company announcement2026-07-23
- 8-K · Company announcement2026-05-29
- 8-K · Company announcement2026-04-30
- 10-Q · Quarterly report2026-04-30
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about TENET HEALTHCARE CORP, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.